Direct Rx Alprazolam C-IV 1mg 60-count bottles: Potential cross-contamination hazard
Direct Rx recalls 60-count Alprazolam C-IV 1mg bottles due to potential cross-contamination at the contract manufacturer. Affected lots expire May 2022.
Recall notice
CGMP Deviations: The Recall is due to the potential cross-contamination at the contract manufacturer (Ultra Tab Laboratories Inc.)
Contact the company
What happened, in plain English
Direct Rx is recalling 1mg Alprazolam C-IV 60-count bottles that may have been contaminated during manufacturing. This could pose health risks to users who take the medication. Read more at govinfonow.com/recall/35191-direct-rx-alprazolam-c-iv-1mg-60-count-bottles-potential.
Source Summary by GovInfoNow · govinfonow.com/recall/35191-direct-rx-alprazolam-c-iv-1mg-60-count-bottles-potential · Updated August 18, 2026 · FDA enforcement record: FDA #D-0650-2022
Cite this page
“Direct Rx Alprazolam C-IV 1mg 60-count bottles: Potential cross-contamination hazard.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35191-direct-rx-alprazolam-c-iv-1mg-60-count-bottles-potential. Based on FDA recall #D-0650-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0650-2022%22&limit=1).
Why it’s dangerous
The medication may have been contaminated during production at a contract manufacturer. Cross-contamination could introduce harmful substances into the product, potentially causing health issues for users.
Who’s affected
People with prescriptions for this medication are affected. Those who have the specific lot number (19AU1910) and expiration date (May 31, 2022) are most at risk.
How to tell if you have this one
Check for the lot number 19AU1910 and expiration date May 31, 2022 on the bottle. The product is a 1mg Alprazolam C-IV 60-count bottle distributed by Direct Rx.
- Brand
Direct Rx- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
FL, GA, LA
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0650-2022 | Alprazolam C-IV 1 mg 60-count bottles, Rx Only, Dist. By: Par Pharmaceutical Chestnut Ridge, NY 10977 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 61919-836-60; Lot #: 19AU1910 Exp. 5/31/22 | 16 bottles |
| D-0651-2022 | Alprazolam C-IV 2 mg, 60-count bottles, Rx Only, Dist. By: Par Pharmaceutical Chestnut Ridge, NY 10977 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 72189-0058-60; Lot #: 07NO1901 Exp. 5/31/22 | 8 bottles |
What to do — step by step
Check Product Details
Look for the lot number 19AU1910 and expiration date May 31, 2022 on the bottle.
Where it went and when
Where it was distributed
Distributed in 3 states.
FDA distribution: “FL, GA, LA” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Florida, Georgia, Louisiana.
Recall timeline
FDA terminated this recall 9 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Direct Rx recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0650-2022 (March 4, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0650-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.